Obesity or Overweight Is Associated with Worse Pathological Response to Neoadjuvant Chemotherapy among Chinese Women with Breast Cancer

• Sheng Chen,

  Affiliations Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, P.R. China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China

  ⨯
• Can-Ming Chen,

  Affiliations Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, P.R. China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China

  ⨯
• Ying Zhou,

  Affiliations Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, P.R. China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China

  ⨯
• Ruo-Ji Zhou,

  Affiliations Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China, Department of Pathology, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, P.R. China

  ⨯
• Ke-Da Yu,

  Affiliations Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, P.R. China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China

  ⨯
• Zhi-Ming Shao

  * E-mail: zhimingshao@yahoo.com

  Affiliations Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, P.R. China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China, Institutes of Biomedical Science, Fudan University, Shanghai, P.R. China

  ⨯